tirzepatide semaglutide equivalent vs and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States Tirzepatide vs Semaglutide Trial Results

Inform each prescriber and agree a monitoring plan

A study published last year in The BMJ, the journal of the British Medical Association, found that the number of patients without diabetes who started GLP-1 treatment in the United States increased from roughly 21,000 in 2019 to 174,000 in 2023, or more than 700%

ideal for regular maintenance or anyone seeking healthy, luminous skin

Full trial results and Research Summary: nej.md/4n1nSl2 In the ATTAIN-1 phase 3, randomized trial, the use of orforglipron, an oral glucagon-like peptide-1 receptor agonist, led to significant mean body-weight reductions in patients with obesity, as compared with placebo

Uncover expert advice, preventative tips, and the truth about dermaplanings effects on acne-prone skin

Why Three Vials Make a Difference Having three vials allows you to pace your routine naturally